LeMaitre Vascular Q3 2024 GAAP EPS $0.49 Beats $0.44 Estimate, Sales $54.819M Beat $53.503M Estimate
Portfolio Pulse from Benzinga Newsdesk
LeMaitre Vascular reported Q3 2024 earnings per share of $0.49, surpassing the analyst estimate of $0.44. The company's sales reached $54.819 million, exceeding the expected $53.503 million and marking a 15.63% increase from the previous year.
October 31, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LeMaitre Vascular's Q3 2024 earnings and sales exceeded analyst expectations, with EPS at $0.49 and sales at $54.819 million, showing strong year-over-year growth.
The company's earnings per share and sales both exceeded analyst expectations, indicating strong financial performance. The significant year-over-year sales growth further supports a positive outlook for the stock in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100